UBS Group’s Traws Pharma TRAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
– Hold
0
– -$1K – 10825
2014
Q2
– Hold
0
– – – 10249

Other funds holding TRAW

UBS Group's TRAW Position: Q3 2026 in Review

UBS Group increased its Traws Pharma (TRAW) stake by 468% in Q3 2026, buying an estimated $9.29K and bringing the position to 19,616 shares worth $11.7K. The position accounts for ﹤0.01% of the portfolio, ranked #8958.

UBS Group first reported a position in TRAW in Q4 2015 and has held it in 36 quarters since. The position peaked at $71K in Q2 2020. 34 funds tracked by Wall St. Rank hold TRAW as of Q3 2026.

  • UBS Group held 19,616 shares of Traws Pharma worth $11.7K as of Q3 2026.
  • UBS Group bought 16,165 Traws Pharma shares in Q3 2026, an estimated $9.29K.
  • Traws Pharma made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #8958 holding.
  • UBS Group first reported a position in Traws Pharma in Q4 2015 and has held it in 36 quarters since.
  • UBS Group's Traws Pharma position peaked at $71K in Q2 2020.
  • 34 funds tracked by Wall St. Rank held Traws Pharma as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.